PROAK Study Tirbanibulin Boosts Quality of Life for Patients With ... - Dermatology Times
| ALM Stock | EUR 8.74 0.07 0.81% |
About 52% of Almirall's investor base is interested to short. The analysis of current outlook of investing in Almirall SA suggests that many traders are impartial regarding Almirall's prospects. The current market sentiment, together with Almirall's historical and current headlines, can help investors time the market. In addition, many technical investors use Almirall SA stock news signals to limit their universe of possible portfolio assets.
Almirall |
PROAK Study Tirbanibulin Boosts Quality of Life for Patients With ... Dermatology Times
Read at news.google.com
 |
Almirall Fundamental Analysis
We analyze Almirall's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Almirall using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Almirall based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Almirall is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Almirall SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Almirall stock to make a market-neutral strategy. Peer analysis of Almirall could also be used in its relative valuation, which is a method of valuing Almirall by comparing valuation metrics with similar companies.
Peers
Almirall Related Equities
| AMP | Amper SA | 10.00 | ||||
| CLNX | Cellnex Telecom | 1.53 | ||||
| MVC | Metrovacesa | 1.04 | ||||
| ENO | Elecnor SA | 0.85 | ||||
| PHM | Pharma Mar | 0.71 | ||||
| ATRY | Atrys Health | 0.64 | ||||
| MAP | Mapfre | 0.40 | ||||
| ALC | Altia Consultores | 1.29 | ||||
| GRF | Grifols SA | 11.46 |
Complementary Tools for Almirall Stock analysis
When running Almirall's price analysis, check to measure Almirall's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Almirall is operating at the current time. Most of Almirall's value examination focuses on studying past and present price action to predict the probability of Almirall's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Almirall's price. Additionally, you may evaluate how the addition of Almirall to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |